Migraine trials in Italy

In Italy 31 Also abroad 249

31 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Study of the Glymphatic System in Migraine
Where
Milan
Age
18 years to 60 years
People
50
Run by
IRCCS San Raffaele
See details and how to joinNCT05907655
No phaseEnrolling by invitation
Studio TIARA: Alessitimia ed Emicrania Cronica
Where
Alessandria
Age
12 years to 65 years
People
350
Run by
Azienda Sanitaria Locale di Alessandria
See details and how to joinNCT06891053
No phaseTaking people
(Italian Migraine Registry, I-GRAINE-NEW)
Where
Roma
Age
18 years and over
People
2,030
Run by
IRCCS San Raffaele Roma
See details and how to joinNCT07163416
Phase 3Taking people
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Where
Cagliari, Florence, Genoa, Milan, Pavia, Rome
Age
12 years to 17 years
People
285 worldwide
Run by
H. Lundbeck A/S
See details and how to joinNCT04965675 · EU 2024-510656-13-00
Phase 3Taking people
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Where
Avellino, Bari, Brescia, Florence, Genoa, Latina, Milan, Padova, Pavia, Pisa, Rome
Age
6 years to 17 years
People
640 worldwide
Run by
Pfizer
See details and how to joinNCT05156398 · EU 2024-512382-13-00
Phase 3Taking people
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Where
Cagliari, Florence, Genoa, Milan, Pavia, Pisa, Rome
Age
6 years to 17 years
People
600 worldwide
Run by
H. Lundbeck A/S
See details and how to joinNCT05164172 · EU 2022-502917-27-00
Phase 3Taking people
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Where
Cagliari, Genoa, Milan, Pavia, Pisa, Rome
Age
6 years to 17 years
People
315 worldwide
Run by
H. Lundbeck A/S
See details and how to joinNCT05897320 · EU 2022-502538-14-00
Phase 3Taking people
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Where
Milan, Rome
Age
12 years to 17 years
People
420 worldwide
Run by
AbbVie
See details and how to joinNCT06810505 · EU 2024-513836-28-00
Phase 3Taking people
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Where
Milan, Palermo, Rome
Age
6 years to 17 years
People
450 worldwide
Run by
AbbVie
See details and how to joinNCT05711394 · EU 2022-501100-94-00
No phaseTaking people
High-Density EEG-MEG-wearable EEG: Comparison of Quantitative Electroencephalographic Indicators as Neurophysiological Markers of Effectiveness of Mindfulness Therapy in Addition to Standard Treatment in Patients With High-frequency Episodic Migraine
Where
Milan
People
40
Run by
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
See details and how to joinNCT06938178
No phaseTaking people
Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)
Where
Milan
Age
18 years and over
People
1,050
Run by
IRCCS San Raffaele
See details and how to joinNCT07720765
Phase 3Taking people
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Where
Bologna, Florence, L'aquila, Milan, Pavia, Rome
Age
18 years to 45 years
People
723 worldwide
Run by
Pfizer
See details and how to joinNCT06641466 · EU 2024-517121-10-00
No phaseTaking people
Chronology and Sequence of Premonitory Symptoms
Where
Latina
Age
18 years to 65 years
People
500
Run by
University of Roma La Sapienza
See details and how to joinNCT07681466
No phaseTaking people
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Where
Florence, Pavia
Age
18 years and over
People
100
Run by
University of Florence
See details and how to joinNCT06409832
No phaseTaking people
i-NEED: NEw migrainE Drugs Database
Where
Milan, Rome
Age
18 years and over
People
2,641
Run by
IRCCS San Raffaele Roma
See details and how to joinNCT07103694
No phaseTaking people
Evaluation of the Performance of the Doraldo-Castelletti Scale in Supporting the Neurologist's Decision to Refer Migraine Patients to Physiotherapy
Where
Milan
Age
18 years to 70 years
People
439
Run by
Istituto Auxologico Italiano
See details and how to joinNCT07626307
No phaseTaking people
The Neuroanatomical and Psychological Correlates of Suggestibility in Patients With Non-Responsive Chronic Migraine
Where
Catanzaro
Age
18 years to 75 years
People
200
Run by
Istituto per la Ricerca e l'Innovazione Biomedica
See details and how to joinNCT07617441
No phaseTaking people
Vortioxetine in Depression and Concomitant Migraine
Where
Rome
Age
18 years and over
People
31
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07579481
No phaseTaking people
Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Control Therapy
Where
Florence
Age
18 years to 65 years
People
30
Run by
University of Florence
See details and how to joinNCT03404336
No phaseTaking people
Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes
Where
Milan
Age
18 years and over
People
250
Run by
IRCCS San Raffaele
See details and how to joinNCT07518069
No phaseTaking people
Neuropsychological Profile Characterization in Patients With Migraine: Cognitive Functioning and Psychological Variables
Where
Milan
Age
18 years to 65 years
People
150
Run by
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
See details and how to joinNCT07233941
No phaseTaking people
Neurogenetic And Hemodynamic Of Migraine Aura And Pfo
Where
Bologna
Age
18 years and over
People
240
Run by
Azienda Usl di Bologna
See details and how to joinNCT07349004
Phase 4Taking people
Exploring Eptinezumab: Unveiling Peripheral and Central Mechanisms of Action and Searching for Biomarkers of Patient Response (EUPHORIA Study)
Where
Milan
Age
18 years and over
People
60
Run by
Ospedale San Raffaele S.r.l.
See details and how to join2024-519337-35-00 · EU 2024-519337-35-00
No phaseTaking people
Gepant treAtments: EffectIveNess and tolERability (GAINER)
Where
Florence, Pavia
Age
18 years and over
People
100
Run by
University of Florence
See details and how to joinNCT05903027
No phaseTaking people
The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study)
Where
Roma
Age
18 years and over
People
50
Run by
University of Florence
See details and how to joinNCT06628921